Internal Medicine, Endocrinology, Diabetes, & Metabolism · Santa Rosa, CA
NPI
1134324585
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3883 Airway Dr Ste 201
Santa Rosa, CA, 95403
Phone (707) 521-7735
Groups this clinician bills Medicare through
Medicare paid, 2024
$343K
31,725 services
Medicare patients, 2024
626
Average age 73
Drug cost, 2024
$2.8M
4,747 prescriptions
Company payments, 2024
$2,438
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Magnotti was code J0897 (injection, denosumab, 1 mg), 8,280 times for 77 patients. In total Michael Magnotti billed 31,725 services in 17 codes, and Medicare paid $343K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 8,280 | 77 | $17.79 | $147K |
| 99214 Office E&M - Established | Office | 974 | 578 | $96.43 | $94K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 577 | 430 | $13.22 | $7,628 |
| 96372 Injection Administration | Office | 323 | 90 | $12.46 | $4,025 |
| 83036 Blood Count | Office | 189 | 132 | $9.50 | $1,795 |
| 95251 Test - Miscellaneous | Office | 131 | 69 | $27.31 | $3,577 |
| 99204 Office E&M - New | Office | 53 | 53 | $107.38 | $5,691 |
By year: 2022 $271K for 26,099 services; 2023 $292K for 30,353 services; 2024 $343K for 31,725 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 189 | 132 | $9.50 | $1,795 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael Magnotti prescribed most often to Medicare patients was Levothyroxine Sodium, with 416 prescriptions and refills. In total Michael Magnotti wrote 4,747 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 416 | 1,123 | 115 | $5,521 |
| Jardiance Empagliflozin | 404 | 930 | 102 | $523K |
| Ozempic Semaglutide | 364 | 604 | 83 | $573K |
| Mounjaro Tirzepatide | 324 | 462 | 58 | $480K |
| Metformin Hcl Generic | 150 | 411 | 42 | $1,812 |
| Alendronate Sodium Generic | 147 | 385 | 44 | $1,813 |
| Trulicity Dulaglutide | 135 | 219 | 31 | $210K |
| Atorvastatin Calcium Generic | 117 | 340 | 46 | $1,138 |
| Rosuvastatin Calcium Generic | 105 | 307 | 31 | $1,813 |
| Liothyronine Sodium Generic | 102 | 262 | 23 | $5,417 |
| Synthroid Levothyroxine Sodium | 101 | 289 | 31 | $8,935 |
| Metformin Hcl Er Metformin Hcl | 99 | 281 | 35 | $1,472 |
| Methimazole Generic | 99 | 252 | 31 | $1,061 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 97 | 242 | 47 | $9,995 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 97 | 228 | 34 | $16K |
Brand drugs: 2,400 claims; generic drugs: 2,017 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Michael Magnotti $2,438 ($2,438 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $1,300.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $1,300 |
| Lilly USA, LLC LLY | 2 | $1,138 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.